close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Arima Genomics, Inc.

News headline image
Arima Genomics Announces Distribution Partnership with Active Motif for Research-Specific Hi-C Sequencing Kits and Services
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Named to Fast Company’s 2026 World Changing Ideas List for Aventa Lymphoma Test
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces Data Presentation at the Association for Molecular Pathology 2025
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing
From Arima Genomics, Inc.
Via Business Wire
News headline image
New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Expands Executive Team With Three Strategic Hires to Advance Clinical Applications of 3D Genomics
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces Appointment of Veteran Genomics Leader Gabrielle Raia as Senior Vice President of Sales
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces Appointments to its Board of Directors
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics and Velsera Announce Partnership to Enable Broad Adoption of Arima Gene Fusion Test in Clinical Laboratories
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces Agreement with Protean BioDiagnostics to Make Arima Gene Fusion Test Widely Available to Clinicians
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics is Enabling Single Cell 3D Genome Exploration of the Human Brain, One Cell at a Time
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces New Partnership with Basepair to Accelerate Bioinformatics Analysis of 3D Genomics Data
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Presents Data on Cancer Structural Variants at the Association of Molecular Pathology Annual Meeting
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational Applications
From Arima Genomics, Inc.
Via Business Wire
News headline image
Arima Genomics Announces New Structural Variant Detection Products
From Arima Genomics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today